A detailed history of Edge Financial Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Edge Financial Advisors LLC holds 2,442 shares of ABT stock, worth $285,225. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,442
Previous 2,725 10.39%
Holding current value
$285,225
Previous $310 Million 10.1%
% of portfolio
0.25%
Previous 0.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$100.07 - $118.13 $28,319 - $33,430
-283 Reduced 10.39%
2,442 $278 Million
Q1 2024

Apr 19, 2024

BUY
$109.52 - $120.96 $298,442 - $329,616
2,725 New
2,725 $310 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Edge Financial Advisors LLC Portfolio

Follow Edge Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Financial Advisors LLC with notifications on news.